Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.67 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.67 |
| ▸ | TUBB | P07437 | 3/20 | 0.67 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.67 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.67 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.67 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.67 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.67 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.67 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.67 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.67 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.67 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.67 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.67 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17507473 | 0.89 | MEN1 (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL12435904 | 0.85 | KMT2A (0.50) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL11142542 | 0.85 | ALDH1A1 (0.63) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL11165263 | 0.84 | ALDH1A1 (0.61) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL11146505 | 0.82 | KMT2A (0.65) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL11136875 | 0.82 | ALDH1A1 (0.59) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL11140714 | 0.81 | ALDH1A1 (0.58) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL13240109 | 0.80 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL30427425 | 0.79 | ALDH1A1 (0.73) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL51894 | 0.79 | ALDH1A1 (0.73) | TUBB1TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2351731-B1 | A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE | INST MED BIOTECHNOLOGY CAMS (CN) | 2016-02-10 | — | — | EP | disclosed |
| US-8710098-B2 | Group of amino substituted benzoyl derivatives and their preparation and their use | Institute of Medicinal Biotechnology Chinese Academy of Medical Science (CN) | 2014-04-29 | — | — | US | disclosed |
| EP-2351731-A1 | A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE | Institute Of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) | 2011-08-03 | — | — | EP | disclosed |
| US-20110178108-A1 | Group of amino substituted benzoyl derivatives and their preparation and their use | Institute of Medicinal Biotechnology Academy of Medical Science (CN) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178108-A1 | Group of amino substituted benzoyl derivatives and their preparation and their use | CUL3, APOBEC3G, BRPF3 | TUBB1 3156/4885TUBB4A 2601/4885TUBB 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.